Firm Management

Mr. Hayward is the Chief Executive Officer of GMO and a member of the GMO Board of Directors. Prior to joining GMO in 2017, he served as the Chief Executive Officer and Chairman of Quantitative Management Associates LLC (QMA) for 11 years. Previously, he was the Head of Client Relations at QMA and Jennison Associates (both affiliates of Prudential Financial, Inc.). Prior to joining QMA and Jennison Associates in 2003, Mr. Hayward served as Managing Director, Head of Institutional Client Services and Marketing at J.P. Morgan Asset Management. Prior to that, he was a Vice President and served in a variety of roles in the investment bank, private bank, and corporate divisions at J.P. Morgan & Co. Mr. Hayward earned his BA in Political Science from Boston College.

Broker check

Mr. Grantham co-founded GMO in 1977 and is a member of GMO’s Asset Allocation team, serving as the firm’s long-term investment strategist. He is a member of the GMO Board of Directors and has also served on the investment boards of several non-profit organizations. Prior to GMO’s founding, Mr. Grantham was co-founder of Batterymarch Financial Management in 1969 where he recommended commercial indexing in 1971, one of several claims to being first. He began his investment career as an economist with Royal Dutch Shell. Mr. Grantham earned his undergraduate degree from the University of Sheffield (U.K.) and an M.B.A. from Harvard Business School. He is a member of the Academy of Arts and Sciences, holds a CBE from the UK and is a recipient of the Carnegie Medal for Philanthropy.

Mr. Bark is the head of GMO’s Global Client Relations team. Previously at GMO, he led the client relations teams outside the U.S. from London. Prior to joining GMO in 2010, he spent eight years at Goldman Sachs Asset Management after an early career serving in the Royal Navy. Mr. Bark earned his BSc in Economics and Politics from the University of Bristol and is a CFA charterholder. 

Broker check

Mr. Feigelson is GMO’s General Counsel. Prior to joining GMO, he served as General Counsel and head of Human Resources for iCapital Network, Inc. Previously, he was an advisor to Aspiration Partners and Bernstein, Litowitz, Berger, and Grossman, as well as General Counsel for Artivest. Prior to that, Mr. Feigelson was Senior Managing Director, General Counsel, Head of Regulatory Affairs, and Director of Corporate Governance for TIAA-CREF, Managing Director and General Counsel for ABN AMRO Bank’s North American Wholesale and Investment Bank, and Vice President and Global Director of Equity Derivatives Compliance for Goldman Sachs & Co. Mr. Feigelson earned his B.A. in American History from Harvard University, his Master’s in International Relations from The London School of Economics, and his J.D. from Columbia University.

Ms. Haley is the Head of Operations, Finance, and Fund Treasury and Tax. She is a partner of the firm. Previously at GMO, she has held several leadership roles within the Operations team, including Head of Operations, Head of Portfolio Operations, and Head of Financial Reporting within Fund Treasury and Tax. Prior to joining GMO in 2009, she was Treasurer and Chief Compliance Officer at Tekla Capital Management LLC (formerly known as Hambrecht & Quist Capital Management LLC). Prior to that, she was a senior manager with PricewaterhouseCoopers LLP where she served clients in the asset management industry. Ms. Haley earned her Master of Science in Accounting from the Isenberg School of Management at the University of Massachusetts, Amherst and her B.A. in Economics and History from Boston University. She is a certified public accountant.

Mr. Inker is head of GMO’s Asset Allocation team and a member of the GMO Board of Directors. He joined GMO in 1992 following the completion of his B.A. in Economics from Yale University.  In his years at GMO, Mr. Inker has served as an analyst for the Quantitative Equity and Asset Allocation teams, as a portfolio manager of several equity and asset allocation portfolios, as co-head of International Quantitative Equities, and as CIO of Quantitative Developed Equities.  He is a CFA charterholder.

Mr. Martin is the Head of Investment Product Strategy at GMO. Previously at GMO, he was the Head of Investment Teams, overseeing the firm’s equity, fixed income, and alternatives teams. Prior to joining GMO in 2017, he worked at Cambridge Associates for more than 10 years, most recently as Head of Global Hedge Fund Research and Managing Director in the Non-Profit Practice. Andy has also held leadership roles within equity research at Credit Suisse First Boston and Donaldson, Lufkin, & Jenrette, Inc. Mr. Martin earned his BA in International Studies and Political Science from Yale University and his MBA from the Amos Tuck School of Business Administration at Dartmouth College.

Mr. Mittaz is a Senior Advisor at GMO and partner of the firm. Previously, he served as GMO’s Chief Operating Officer responsible globally for IT, Operations, Fund Treasury and Tax, Risk Monitoring, and Finance. Prior to joining GMO in 2010, Mr. Mittaz held numerous positions at UBS Global Asset Management most recently as their chief operating officer; he was also global head of Operations and IT as well as the global head of operational risk management. Previously, Mr. Mittaz was the chief operating officer of global fixed income and currency at Goldman Sachs Asset Management. Mr. Mittaz received his Master’s degree and Ph.D. in Finance from the University of Zurich. He is a CFA charterholder.

Mr. Pottle is GMO’s Chief Compliance Officer. Previously at GMO, he has served as General Counsel on an interim basis and as legal counsel. Prior to joining GMO in 2000, he was a manager in the SEC registration group of Scudder Kemper Investments. Previously he was a legal product manager with Fidelity Investments. Mr. Pottle earned his B.A. in Political Science from Hobart College and his J.D. from Suffolk University.

Dr. Sakoulis is the Head of Investment Teams at GMO. He previously worked at GMO from 2009 to 2014 leading quantitative research for GMO’s Emerging Markets Equity team. Prior to rejoining GMO in 2020, he was most recently a Managing Director and Head of Global Multi-Asset Solutions for QMA, where he focused on systematic total and absolute return investment solutions. Before that, he led QMA’s Global Portfolio Solutions group. Previously, Dr. Sakoulis also served as the Director of European Equity Strategies for Numeric Investors and as a Director for UBS O’Connor. He earned his BA in Economics and BS in Statistics from San Francisco State University and his MA in Economics and PhD in Financial Econometrics from the University of Washington.

Mr. Socher is GMO’s Chief Technology Officer. He has more than thirty years’ experience building and leading technology organizations for global financial firms. He also currently serves on the Board of LayerOne Financial, which offers a cross-asset class investment management platform. Immediately prior to joining GMO, he was the Chief Technology Officer of VaraQuest, a firm he founded focused on using machine learning to construct and manage investment portfolios. Previously, Mr. Socher held Chief Information and Technology Officer positions at Fortress Investment Group, Amaranth Group, and Susquehanna International Group. Prior to that, he led the technology effort for the Capital Markets Group at NationsBank Capital Markets. Mr. Socher earned his BEconSci in Computer Science and Econometrics and BSc Hons in Computer Science with a focus on Artificial Intelligence from the University of the Witwatersrand, and his MBA in International Finance from Stern School of Business at New York University.

Ms. Zimmerman is the head of global human resources. Prior to joining GMO in 2013, she held numerous positions at BNY Mellon Asset Management most recently as managing director and previously as vice president. Ms. Zimmerman earned her B.S. in Business Administration from Bentley College.